NCT00960882View on ClinicalTrials.gov

Gastric Tolerability and Pharmacokinetics of DMMET-01

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

April 30, 2008

Conditions
Healthy
Interventions
DRUG

DMMET-01

1050.6 mg daily for 30 days

Trial Locations (1)

64460

Pharmacology and toxicology department, UANL, Monterrey

All Listed Sponsors
lead

Laboratorios Silanes S.A. de C.V.

INDUSTRY

NCT00960882 - Gastric Tolerability and Pharmacokinetics of DMMET-01 | Biotech Hunter | Biotech Hunter